0
Abstract: Poster Presentations |

STUDY OF SOME INFLAMMATORY MARKERS IN CHILDREN WITH MODERATE PERSISTENT BRONCHIAL ASTHMA BEFORE AND AFTER THERAPY WITH INHALED CORTICOSTEROIDS FREE TO VIEW

Mohammed A. Ragab, MD*; Maged M. Eissa, MD
Author and Funding Information

Faculty of Medicine, Alexandria University, Alexandria, Egypt


Chest


Chest. 2009;136(4_MeetingAbstracts):33S. doi:10.1378/chest.136.4_MeetingAbstracts.33S
Text Size: A A A
Published online

Abstract

PURPOSE:  To study some inflammatory markers before and after inhaled corticosteroid (ICS)therapy in children with moderate persistent bronchial asthma and to correlate the changes in their levels, if any, with recurrence of the clinical manifestations.

METHODS:  30 children aged 5–15 year with bronchial asthma and 20 age and sex matched healthy children (control group) were subjected to measurement of the levels of hypertonic saline-induced sputum eosinophils , absolute eosinophilic count AEC, eosinophilic cationic protein ECP, and tumor necrosis factor-∼ TNF-∼ in addition to measurement of forced expiratory volume in 1 second to forced vital capacity ratio (FEV1/FVC). the first sample was taken from the patients and control before the start of therapy while in the patients group two other samples were taken. The second sample was taken after 3 months of ICS therapy ( after control of the clinical manifestations) and the third was taken with reappearance of the clinical manifestations either during or after complete withdrawal of the ICS therapy (over 4 months.

RESULTS:  Our patients in the pretreatment sample had significantly higher levels of sputum eosinophis, AEC, ECP, TNF- ∼, and FEV1/FVC compared to the controls (P = 0.001 for the five variants). Compared to the pretreatment values these values except AEC decreased significantly after 3 months of ICS (P = 0.001, 0.07, 0.001, 0.001, and 0.001 respectively). Relapse occurred in 25 patients during withdrawal of the ICS therapy and 5 patients remained free of symptoms after complete stoppage of the treatment. Relapse was associated with significant increase in the levels of TNF-∼ and sputum eosinophils in the third sample compared to the second sample (P = 0.02, and 0.045 respectively).

CONCLUSION:  Inflammation in bronchial asthma is evidenced by increased levels of the inflammatory markers. ICS therapy is effective against this inflammation. TNF-∼ followed by sputum eosinophils are sensitive predictors of relapse in the children suffering from bronchial asthma.

CLINICAL IMPLICATIONS:  Physicians can monitor bronchial asthma using non-invasive measurements. Researches to find out specific anti-inflammatory markers therapy should be activated.

DISCLOSURE:  Mohammed Ragab, No Financial Disclosure Information; No Product/Research Disclosure Information

Tuesday, November 3, 2009

12:45 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543